Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas

This study has suspended participant recruitment.
(1 patient died of uncertain cause but possibly related to drug. Regulatory currently reviewing)
Sponsor:
Collaborators:
Pfizer
Information provided by (Responsible Party):
Chie-Schin Shih, Indiana University
ClinicalTrials.gov Identifier:
NCT01402817
First received: July 25, 2011
Last updated: August 25, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)